171 related articles for article (PubMed ID: 12599063)
21. Epidemiology of pathogenic Neisseria meningitidis serogroup B serosubtypes in Malta: implications for introducing PorA based vaccines.
Pace D; Cuschieri P; Galea Debono A; Attard-Montalto S
Vaccine; 2008 Nov; 26(47):5952-6. PubMed ID: 18801401
[TBL] [Abstract][Full Text] [Related]
22. Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001.
Tsang RS; Squires SG; Tam TW
Can J Microbiol; 2003 Oct; 49(10):633-8. PubMed ID: 14663497
[TBL] [Abstract][Full Text] [Related]
23. Whole genome typing of the recently emerged Canadian serogroup W Neisseria meningitidis sequence type 11 clonal complex isolates associated with invasive meningococcal disease.
Tsang RSW; Ahmad T; Tyler S; Lefebvre B; Deeks SL; Gilca R; Hoang L; Tyrrell G; Van Caeseele P; Van Domselaar G; Jamieson FB
Int J Infect Dis; 2018 Apr; 69():55-62. PubMed ID: 29414677
[TBL] [Abstract][Full Text] [Related]
24. Rapid molecular identification of Neisseria meningitidis isolates using the polymerase chain reaction followed by single-stranded conformation polymorphism analysis.
Kesanopoulos K; Tzanakaki G; Velegraki A; Tegos N; Caugant DA; Menounos P; Kourea-Kremastinou J; Levidiotou-Stefanou S
FEMS Immunol Med Microbiol; 2005 Aug; 45(2):143-9. PubMed ID: 16051066
[TBL] [Abstract][Full Text] [Related]
25. Serosubtypes and PorA types of Neisseria meningitidis serogroup B isolated in Brazil during 1997--1998: overview and implications for vaccine development.
Sacchi CT; Lemos AP; Popovic T; De Morais JC; Whitney AM; Melles CE; Brondi LM; Monteiro LM; Paiva MV; Solari CA; Mayer LW
J Clin Microbiol; 2001 Aug; 39(8):2897-903. PubMed ID: 11474010
[TBL] [Abstract][Full Text] [Related]
26. Typing of Neisseria meningitidis isolates from patients with invasive disease by molecular analysis of porin genes.
Stefanelli P; Fazio C; Mastrantonio P
New Microbiol; 2001 Apr; 24(2):149-55. PubMed ID: 11346298
[TBL] [Abstract][Full Text] [Related]
27. Identification of Neisseria meningitidis sequence type 66 in Poland.
Skoczynska A; Konior R; Sadowy E; Piatkowska-Smietanska M; Lelek B; Gniadkowski M; Hryniewicz W
Clin Microbiol Infect; 2004 Sep; 10(9):848-50. PubMed ID: 15355419
[TBL] [Abstract][Full Text] [Related]
28. Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study.
Knol MJ; Hahné SJM; Lucidarme J; Campbell H; de Melker HE; Gray SJ; Borrow R; Ladhani SN; Ramsay ME; van der Ende A
Lancet Public Health; 2017 Oct; 2(10):e473-e482. PubMed ID: 29253430
[TBL] [Abstract][Full Text] [Related]
29. Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team.
Tondella ML; Popovic T; Rosenstein NE; Lake DB; Carlone GM; Mayer LW; Perkins BA
J Clin Microbiol; 2000 Sep; 38(9):3323-8. PubMed ID: 10970378
[TBL] [Abstract][Full Text] [Related]
30. Genetic characterization of a Neisseria meningitidis cluster in Queensland, Australia.
Abady NR; Guglielmino CJD; Graham RM; Adelskov J; Smith HV; Patel BKC; Jennison AV
Can J Microbiol; 2017 Jul; 63(7):644-647. PubMed ID: 28460189
[TBL] [Abstract][Full Text] [Related]
31. Development of the epidemiological situation in invasive meningococcal disease in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37.
Krízová P; Musílek M; Kalmusová J
Cent Eur J Public Health; 1997 Dec; 5(4):214-8. PubMed ID: 9457424
[TBL] [Abstract][Full Text] [Related]
32. Serological correlates of protection against meningococci in a cohort of university students, before and during an outbreak of serogroup C infection.
Williams JN; Jones GR; Christodoulides M; Heckels JE
J Infect Dis; 2003 May; 187(9):1433-41. PubMed ID: 12717625
[TBL] [Abstract][Full Text] [Related]
33. Rapid laboratory detection of meningococcal disease outbreaks caused by serogroup C Neisseria meningitidis.
Killoran PB; O'Connell J; Mothershed EA; Probert WS
J Microbiol Methods; 2006 Nov; 67(2):330-8. PubMed ID: 16740329
[TBL] [Abstract][Full Text] [Related]
34. Variable-number tandem repeat analysis of meningococcal isolates belonging to the sequence type 162 complex.
Yazdankhah SP; Kesanopoulos K; Tzanakaki G; Kremastinou J; Caugant DA
J Clin Microbiol; 2005 Sep; 43(9):4865-7. PubMed ID: 16145161
[TBL] [Abstract][Full Text] [Related]
35. Genetic and antigenic characterization of Canadian invasive Neisseria meningitidis serogroup C (MenC) case isolates in the post-MenC conjugate vaccine era, 2009-2013.
Tsang RS; Hoang L; Tyrrell G; Horsman G; Wylie J; Jamieson FB; Lefebvre B; Taha MK
J Med Microbiol; 2015 Feb; 64(Pt 2):174-9. PubMed ID: 25627205
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a new Neisseria meningitidis serogroup C clone from China.
Peng J; Zhang X; Shao Z; Yang L; Jin Q
Scand J Infect Dis; 2008; 40(1):63-6. PubMed ID: 17852942
[TBL] [Abstract][Full Text] [Related]
37. Four-month outbreak of invasive meningococcal disease caused by a rare serogroup B strain, identified through the use of molecular PorA subtyping, England, 2013.
Chatt C; Gajraj R; Hawker J; Neal K; Tahir M; Lawrence M; Gray SJ; Lucidarme J; Carr AD; Clark SA; Fowler T
Euro Surveill; 2014 Nov; 19(44):. PubMed ID: 25394258
[TBL] [Abstract][Full Text] [Related]
38. Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage.
Lucidarme J; Hill DM; Bratcher HB; Gray SJ; du Plessis M; Tsang RS; Vazquez JA; Taha MK; Ceyhan M; Efron AM; Gorla MC; Findlow J; Jolley KA; Maiden MC; Borrow R
J Infect; 2015 Nov; 71(5):544-52. PubMed ID: 26226598
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology of meningococcal disease in southern Brazil from 1995 to 2003, and molecular characterization of Neisseria meningitidis using multilocus sequence typing.
Baethgen LF; Weidlich L; Moraes C; Klein C; Nunes LS; Cafrune PI; Lemos AP; Rios SS; Abreu MF; Kmetzsch C; Sperb AF; Riley LW; Rossetti ML; Zaha A
Trop Med Int Health; 2008 Jan; 13(1):31-40. PubMed ID: 18290999
[TBL] [Abstract][Full Text] [Related]
40. [The first effect of the national vaccination campaign against meningococcal-C disease: a rapid and sharp decrease in the number of patients].
de Greeff SC; de Melker HE; Spanjaard L; van den Hof S; Dankert J
Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1132-5. PubMed ID: 12822525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
